Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Koray Sahin

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Heliyon|September 27, 2024
Immune checkpoint blockade and CAR T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma: Challenges and opportunitiesTaha Koray Sahin, Serkan Akin
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 21, 2024
The role of the microbiome in head and neck squamous cell cancersTaha Koray Sahin, Meliha Cagla Sonmezer
Clinical Nutrition ESPEN|August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysisTaha Koray Sahin, Deniz Can Guven
Breast Cancer Research and Treatment|January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin
Critical Reviews in Food Science and Nutrition|September 16, 2021
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapyTaha Koray Sahin, Birdal Bilir, Omer Kucuk
Expert Review of Anticancer Therapy|March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitorsTaha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers|January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung CancerDeniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Expert Review of Anticancer Therapy|March 9, 2026
Harnessing the Power of artificial intelligence for clinical trials in cancerGamze Sonmez, Yigit Yazarkan, Taha Koray Sahin, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Heliyon|September 27, 2024
Immune checkpoint blockade and CAR T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma: Challenges and opportunitiesTaha Koray Sahin, Serkan Akin
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 21, 2024
The role of the microbiome in head and neck squamous cell cancersTaha Koray Sahin, Meliha Cagla Sonmezer
Clinical Nutrition ESPEN|August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysisTaha Koray Sahin, Deniz Can Guven
Breast Cancer Research and Treatment|January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin
Critical Reviews in Food Science and Nutrition|September 16, 2021
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapyTaha Koray Sahin, Birdal Bilir, Omer Kucuk
Expert Review of Anticancer Therapy|March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitorsTaha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers|January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung CancerDeniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Expert Review of Anticancer Therapy|March 9, 2026
Harnessing the Power of artificial intelligence for clinical trials in cancerGamze Sonmez, Yigit Yazarkan, Taha Koray Sahin, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Pageof 8